SUNPHARMA a rating kept

as of Thu 7 May 15:30

SUN PHARMACEUTICAL IND L filed a rating kept of CRISIL AAA on Thu 7 May 2026.

Its size: reaffirmed.

Where it came from

as of Thu 7 May 15:30
Sources
Filed
NSE · 2026-05-07 18:30 IST
Document
raw/nse_announcement_docs/2026-05-07/d55cc3670b0c_d55cc3670b0c_SUNSEC_07052026182926_Intimation_to_SE_-_Credit_Rating.pdf · SHA-256 d55cc3670b0c
Read from
“reaffirmed the rating on the long-term bank facilities for Sun Pharmaceutical Industries Limited (“Sun Pharma”), at ‘Crisil AAA’ and short-term bank facilities and commercial paper at ‘Crisil A1+’” · page 1 · characters 710–910
Read by
claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
Measured against
the steps of the rating scale · as of 7 May 2026
Kind
credit rating action

What such filings have been followed by

as of Thu 7 May 15:30
OverInBeyond its normal dayBeyond what options priced
This stockthe next session0 of 42 of 4
This stockthe next five sessions0 of 31 of 3
Its industry (Healthcare)the next session5 of 5725 of 57
Its industry (Healthcare)the next five sessions6 of 5527 of 55
Every stockthe next session115 of 1,007428 of 1,006
Every stockthe next five sessions134 of 997457 of 964

Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.